Search

Sodium ion batteries are favored in stationary and large scale power storage due to their low cost and nontoxicity. As the lithium is replaced with sodium due to the cost motive, a cheap processing method is needed to maintain the cell price as low as possible. We report an ultra-fast synthesis method that utilizes the high microwave absorbance of silicon carbide content in rice straw ash. Amorphous/maricite mixtures of sodium iron phosphates-carbon composites (NaFePO 4 -C) are synthesized, crystallized, and carbon coated using one-step microwave heating. The sodium ion electroactive composites are prepared using different microwave heating durations ranging from 30 to 100 s. High purity inert gases are not needed during synthesis, processing, and even at cell assembly. The materials are characterized by elemental analysis techniques, X-ray diffraction (XRD), scanning/transmission electron microscope (SEM/TEM), and Raman spectroscopy. The electrochemical performance of the synthesized nanocomposites is examined as sodium ion battery cathode and as symmetric supercapacitors. The optimum synthesis time is 60 s for the application as sodium ion batteries and as a supercapacitor. The maximum specific capacity is 108.4 mA h g -1 at 0.2 C in the case of using it as a battery cathode. While the capacitance is 86 F g -1 at 0.5 A g -1 as a supercapacitor. The capacity retention is 92.85% after 40 cycles at 0.2 C as sodium ion battery electrode. For supercapacitor, the capacity retention is 81.7% after 1000 cycles., (© 2022. The Author(s).)

Autism spectrum disorder (ASD) is a neurodevelopmental disorder of heterogenous etiology exhibiting a challenge in understanding its exact neuro-pathophysiology. Recently, peroxisome proliferator activated receptor (PPAR)-α activation was found to play a fundamental role in neuroprotection and improving autistic-like-behaviors in experimental animal models of ASD through alleviating neuroinflammation, oxidative-stress, astrocyte reactivity, tauopathy in addition to its favorable role in metabolic regulation, thus attracting attention as a possible target in treatment of ASD. This study aimed to investigate the role of PPAR-α, astrocytic dysfunction and tauopathy in ASD and detect the possible neuroprotective effects of metformin (MET), through PPAR-α activation, and risperidone (RIS) either monotherapy or in combination in alleviating autistic-like-changes at behavioral and neurobiological levels in male Wistar rats. Pregnant female Wistar rats received valproic-acid (VPA) to induce autistic-like-behavioral and neurobiological alterations in their offspring. Chronic intra-peritoneal MET (100 mg/kg/day) and RIS (1 mg/kg/day) either monotherapy or in combination started from postnatal day (PND) 24 till PND61 (38 days). Prenatal VPA exposure simulated the autistic core behaviors associated with neurochemical and histopathological neurodevelopmental degenerative changes. Both MET and RIS either monotherapy or in combination were able to reverse these changes. The effect of MET was comparable to RIS. Moreover, MET was able to alleviate the RIS induced weight gain and improve cognitive functions highlighting its promising adjunctive role in alleviating ASD pathophysiology. Our study highlighted the favorable effects of MET and RIS both in monotherapy and in combination in alleviating the autistic-like-changes and proposed PPAR-α activation along with restoring astrocytes homeostasis as promising targets in novel therapeutic strategies in ASD., (Copyright © 2022 Elsevier Inc. All rights reserved.)

Background: Emerging evidence suggests that dysregulated apoptosis might be implicated in the pathogenesis of multiple sclerosis (MS). The aim of the current study was to evaluate the expression of Apoptotic protease activating factor-1 (APAF1) mRNA and its potential regulator miR-484 in relapsing remitting MS patients (RRMS) and to investigate their role as potential disease biomarkers., Methods: After Bioinformatic analysis was conducted and revealed miR-484 involvement in the regulation of APAF-1 gene expression. Reverse Transcription-quantitative Real-Time PCR (RT-qPCR) was performed to detect the expression levels of APAF-1 and miR-484 in the peripheral blood mononuclear cells (PBMCs) of 34 RRMS patients recruited from the MS clinic of kasr al ainy hospital- faculty of medicine-Egypt and 34 healthy controls., Results: APAF-1 mRNA was significantly downregulated in patients whereas miR-484 expression was upregulated compared to controls (p < 0.01). Sensitivity and specificity of APAF-1 and miR-484 to diagnose MS was (85.3%, 76.5%) and (88.2% and 86.7%) respectively., Conclusion: APAF-1 and miR-484 could play a role as potential MS diagnostic biomarkers. However, absence of a control group of patients with other inflammatory diseases in our study warrants further research to corroborate our findings., (Copyright © 2022 Elsevier B.V. All rights reserved.)